Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/3/15 → 5/2/18 |
Funding
- ImmunoCellular Therapeutics Limited: $54,785.00
15-GBM-10-IT (ICT-107-301) A Phase III study of ICT-107 plus maintenance temozolomide (TMZ) in newly diagnosed GBM
- Villano, PhD, John (PI)
- St Clair, William (CoI)
- Thind, Ravneet (CoI)